ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical competence statement on management of patients with advanced heart failure and cardiac transplant: A report of the ACCF/AHA/ACP task force on clinical competence and training

Journal of the American College of Cardiology

Volumn 56, Issue 5, 2010, Pages 424-453

  Francis, Gary S ^a   Greenberg, Barry H ^a   Hsu, Daphne T ^a   Jaski, Brian E ^a   Jessup, Mariell ^a   Lewinter, Martin M ^a   Pagani, Francis D ^a   Pia, Ileana L ^a   Semigran, Marc J ^a   Walsh, Mary Norine ^a   Wiener, David H ^a   Yancy Jr , Clyde W ^a  

^a NONE

Author keywords

ACCF Clinical Competence Statement; cardiac transplant; competence; heart failure

Indexed keywords

HYDRALAZINE; NESIRITIDE; NITRATE; NITROPRUSSIDE SODIUM;

CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CERTIFICATION; CLINICAL COMPETENCE; CONSENSUS DEVELOPMENT; HEART ARRHYTHMIA; HEART ASSIST DEVICE; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART TRANSPLANTATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; KNOWLEDGE; MEDICAL EDUCATION; PALLIATIVE THERAPY; PATIENT CARE; PATIENT MONITORING; PATIENT REFERRAL; PEER REVIEW; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SELF CARE; ADOLESCENT; ARTICLE; CARDIOLOGY; CARDIOVASCULAR DISEASE; CHILD; CURRICULUM; DISEASE MANAGEMENT; EDUCATION; FEMALE; MALE; MEDICAL SOCIETY; METHODOLOGY; STANDARD;

ADOLESCENT; CARDIOLOGY; CARDIOVASCULAR DISEASES; CHILD; CLINICAL COMPETENCE; CURRICULUM; DISEASE MANAGEMENT; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; MALE; SOCIETIES, MEDICAL;

EID: 77955327295     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.04.014     Document Type: Review

References (142)

1. J.B. Young, W.T. Abraham, and R.C. Bourge Task force 8: training in heart failure endorsed by the Heart Failure Society of America J Am Coll Cardiol 51 2008 383 389
2. J.N. Cohn, D.G. Archibald, and S. Ziesche Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study N Engl J Med 314 1986 1547 1552
3. P.A. Keown, C.R. Stiller, and G. Carruthers Cyclosporine: mechanism of action, measurement and clinical use Br J Clin Pract 40 1986 149 156
4. A. Welz, B. Reichart, and P. Uberfuhr Cyclosporine as the main immunosuppressant in clinical heart transplantation: correlation of hepatotoxicity and nephrotoxicity Transplant Proc 16 1984 1212 1213
5. National Organ Transplantation Act http://www.unos.org/ SharedContentDocuments/NOTA-as-amended-Jan-2008.pdf Accessed April 27, 2010
6. J.Z. Ayanian, M.B. Landrum, E. Guadagnoli, and P. Gaccione Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction N Engl J Med 347 2002 1678 1686
7. J.M. Foody, S.S. Rathore, and Y. Wang Physician specialty and mortality among elderly patients hospitalized with heart failure Am J Med 118 2005 1120 1125 (Pubitemid 41362612)
8. G.A. Beller, R.O. Bonow, and V. Fuster ACCF 2008 recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS 3) (revision of the 2002 COCATS Training Statement) J Am Coll Cardiol 51 2008 335 338
9. UNOS Bylaws, Appendix B, Attachment I, XIII http://www.unos.org/ policiesandBylaws2/bylaws/UNOSByLaws/pdfs/bylaw-122.pdf Accessed May 21, 2010
10. M.M. Boucek, P. Aurora, and L.B. Edwards Registry of the International Society for Heart and Lung Transplantation: tenth official pediatric heart transplantation report2007 J Heart Lung Transplant 26 2007 796 807 (Pubitemid 47199083)
11. E.D. Blume, D.C. Naftel, and H.J. Bastardi Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study Circulation 113 2006 2313 2319
12. R.E. Shaddy, M.M. Boucek, and D.T. Hsu Carvedilol for children and adolescents with heart failure: a randomized controlled trial JAMA 298 2007 1171 1179
13. T.P. Graham Jr., and R.H. Beekman III ACCF/AHA/AAP recommendations for training in pediatric cardiology Training guidelines for pediatric cardiology fellowship programs J Am Coll Cardiol 46 2005 1380 1381
14. C.E. Canter, R.E. Shaddy, and D. Bernstein Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation 115 2007 658 676
15. T.S. Maxey, W.B. Keeling, and K.E. Sommers Surgical alternatives for the palliation of heart failure: a prospectus J Card Fail 11 2005 670 676
16. B.P. Griffith Surgical treatment of congestive heart failure: evolving options Ann Thorac Surg 76 2003 S2254 S2259
17. O.H. Frazier, E.A. Rose, and M.C. Oz Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation J Thorac Cardiovasc Surg 122 2001 1186 1195
18. E.A. Rose, A.C. Gelijns, and A.J. Moskowitz Long-term mechanical left ventricular assistance for end-stage heart failure N Engl J Med 345 2001 1435 1443
19. M.A. Acker, S. Bolling, and R. Shemin Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial J Thorac Cardiovasc Surg 132 2006 568 577
20. D. Joyce, M. Loebe, and G.P. Noon Revascularization and ventricular restoration in patients with ischemic heart failure: the STICH trial Curr Opin Cardiol 18 2003 454 457
21. O.P. Almeida, and L. Flicker The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning Intern Med J 31 2001 290 295
22. G. Zuccala, C. Pedone, and M. Cesari The effects of cognitive impairment on mortality among hospitalized patients with heart failure Am J Med 115 2003 97 103
23. S.D. Katz Mechanisms and treatment of anemia in chronic heart failure Congest Heart Fail 10 2004 243 247
24. J. Ezekowitz, F.A. McAlister, and K.H. Humphries The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease J Am Coll Cardiol 44 2004 1587 1592
25. T.D. Bradley, A.G. Logan, and R.J. Kimoff Continuous positive airway pressure for central sleep apnea and heart failure N Engl J Med 353 2005 2025 2033
26. F. Levy, M. Laurent, and J.L. Monin Aortic valve replacement for low-flow/low-gradient aortic stenosis operative risk stratification and long-term outcome: a European multicenter study J Am Coll Cardiol 51 2008 1466 1472
27. K.A. Eagle, R.A. Guyton, and R. Davidoff ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) J Am Coll Cardiol 44 2004 e213 e310
28. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 53 2009 e1 e90
29. Y.O. Xu-Cai, D.J. Brotman, and C.O. Phillips Outcomes of patients with stable heart failure undergoing elective noncardiac surgery Mayo Clin Proc 83 2008 280 288
30. M.R. Costanzo, S. Augustine, and R. Bourge Selection and treatment of candidates for heart transplantation: a statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association Circulation 92 1995 3593 3612
31. Executive summary HFSA 2006 Comprehensive Heart Failure Practice Guideline J Card Fail 12 2006 10 38
32. M.R. Mehra, J. Kobashigawa, and R. Starling Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates2006 J Heart Lung Transplant 25 2006 1024 1042
33. M. Jessup, N. Banner, and S. Brozena Optimal pharmacologic and non-pharmacologic management of cardiac transplant candidates: approaches to be considered prior to transplant evaluation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates2006 J Heart Lung Transplant 25 2006 1003-23.
34. Lindenfeld J, Albert NM, Boehmer JP, et al. HFSA 2010 comprehensive heart failure practice guideline. Section 12: evaluation and management of patients with acute decompensated heart failure. J Card Fail. 2010;16:e134-56.
35. Poston RS, Griffith BP. Heart transplantation. J Intensive Care Med. 2004;19:3-12.
36. Taylor DO, Edwards LB, Aurora P, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult heart transplant report-2008. J Heart Lung Transplant. 2008;27:943-56.
37. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twentyfourth official adult heart transplant report-2007. J Heart Lung Transplant. 2007;26:769-81.
38. Stehlik J, Starling RC, Movsesian MA, et al. Utility of long-term surveillance endomyocardial biopsy: a multi-institutional analysis. J Heart Lung Transplant. 2006;25:1402-9.
39. Shiba N, Chan MC, Kwok BW, Valantine HA, Robbins RC, Hunt SA. Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience. J Heart Lung Transplant. 2004;23:155-64.
40. Stewart S, Winters GL, Fishbein MC, et al. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant. 2005;24:1710-20.
41. Reed EF, Demetris AJ, Hammond E, et al. Acute antibodymediated rejection of cardiac transplants. J Heart Lung Transplant. 2006;25:153-9.
42. Uber WE, Self SE, Van Bakel AB, Pereira NL. Acute antibodymediated rejection following heart transplantation. Am J Transplant. 2007;7:2064-74.
43. Hunt SA, Haddad F. The changing face of heart transplantation. J Am Coll Cardiol. 2008;52:587-98.
44. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357:2601-14.
45. Kobashigawa JA, Starling RC, Mehra MR, et al. Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients. J Heart Lung Transplant. 2006;25:1063-9.
46. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341:625-34.
47. Dembitsky WP, Moore CH, Holman WL, et al. Successful mechanical circulatory support for noncoronary shock. J Heart Lung Transplant. 1992;11:129-35.
48. Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J. 2005;26:1276-83.
49. Baughman KL, Jarcho JA. Bridge to life: cardiac mechanical support. N Engl J Med. 2007;357:846-9.
50. Copeland JG, Smith RG, Arabia FA, et al. Cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859-67.
51. Holman WL, Kormos RL, Miller MA, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant. 2008;27:s244. Abstract.
52. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885-96.
53. Haj-Yahia S, Birks EJ, Rogers P, et al. Midterm experience with the Jarvik 2000 axial flow left ventricular assist device. J Thorac Cardiovasc Surg. 2007;134:199-203.
54. Noon GP, Morley DL, Irwin S, et al. Clinical experience with the MicroMed DeBakey ventricular assist device. Ann Thorac Surg. 2001;71:S133-8.
55. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497-505.
56. Jaski BE, Lingle RJ, Kim J, et al. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial. J Heart Lung Transplant. 1999;18:1031-40.
57. Haft J, Armstrong W, Dyke DB, et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation. 2007;116:I8-15.
58. Mancini D, LeJemtel T, Aaronson K. Peak VO(2): a simple yet enduring standard. Circulation. 2000;101:1080-2.
59. Mudge GH Jr., Fang JC, Smith C, Couper G. The physiologic basis for the management of ventricular assist devices. Clin Cardiol. 2006;29:285-9.
60. Jaski BE, Kim J, Maly RS, et al. Effects of exercise during long-term support with a left ventricular assist device: results of the experience with left ventricular assist device with exercise (EVADE) pilot trial. Circulation. 1997;95:2401-6.
61. Jaski BE, Miller DA, Hoagland PM, et al. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction. J Heart Lung Transplant. 2005;24:2060-7.
62. Liao KK, Miller L, Toher C, et al. Timing of transesophageal echocardiography in diagnosing patent foramen ovale in patients supported with left ventricular assist device. Ann Thorac Surg. 2003;75:1624-6.
63. Vollkron M, Voitl P, Ta J, et al. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant. 2007;26:819-25.
64. Lazar RM, Shapiro PA, Jaski BE, et al. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation. 2004;109:2423-7.
65. Chinn R, Dembitsky W, Eaton L, et al. Multicenter experience: prevention and management of left ventricular assist device infections. ASAIO J. 2005;51:461-70.
66. Holdy K, Dembitsky W, Eaton LL, et al. Nutrition assessment and management of left ventricular assist device patients. J Heart Lung Transplant. 2005;24:1690-6.
67. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-146.
68. Nieminen MS, Harjola VP. Definition and epidemiology of acute heart failure syndromes. Am J Cardiol. 2005;96:5G-10G.
69. Graff L, Orledge J, Radford MJ, et al. Correlation of the Agency for Health Care Policy and Research congestive heart failure admission guideline with mortality: peer review organization voluntary hospital association initiative to decrease events (PROVIDE) for congestive heart failure. Ann Emerg Med. 1999;34:429-37.
70. Adams KF Jr., Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209-16.
71. Fonarow GC, Abraham WT, Albert NM, et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA. 2007;297:61-70.
72. Nieminen MS, Bohm M, Cowie MR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J. 2005;26:384-416. (Pubitemid 40283098)
73. Fonarow GC, Heywood JT, Heidenreich PA, et al. Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2007;153:1021-8.
74. Echols MR, Felker GM, Thomas KL, et al. Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIMECHF trial. J Card Fail. 2006;12:684-8.
75. Nohria A, Lewis E, Stevenson LW. Medical management of advanced heart failure. JAMA. 2002;287:628-40.
76. Fonarow GC, Adams KF Jr., Abraham WT, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA. 2005;293:572-80.
77. Peacock WF, Fonarow GC, Emerman CL, et al. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. Cardiology. 2007;107:44-51.
78. Mullens W, Abrahams Z, Francis GS, et al. Sodium nitroprusside for advanced low-output heart failure. J Am Coll Cardiol. 2008;52:200-7.
79. Winck JC, Azevedo LF, Costa-Pereira A, et al. Efficacy and safety of noninvasive ventilation in the treatment of acute cardiogenic pulmonary edema: a systematic review and meta-analysis. Crit Care. 2006;10:R69.
80. Peter JV, Moran JL, Phillips-Hughes J, et al. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary oedema: a meta-analysis. Lancet. 2006;367:1155-63.
81. Felker GM, Adams KF Jr., Konstam MA, et al. The problem of decompensated heart failure: nomenclature, classification, and risk stratification. Am Heart J. 2003;145:S18-25.
82. Stough WG, O'Connor CM, Gheorghiade M. Overview of current noninodilator therapies for acute heart failure syndromes. Am J Cardiol. 2005;96:41G-6G.
83. Heart Failure Society of America. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2006;12:10-38.
84. Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation. 2004;110:1514-7.
85. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61-7.
86. Krumholz HM, Amatruda J, Smith GL, et al. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002;39:83-9.
87. Kasper EK, Gerstenblith G, Hefter G, et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol. 2002;39:471-80.
88. DeBusk RF, Miller NH, Parker KM, et al. Care management for low-risk patients with heart failure: a randomized, controlled trial. Ann Intern Med. 2004;141:606-13.
89. Phillips CO, Wright SM, Kern DE, et al. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA. 2004;291:1358-67.
90. Goldberg LR, Piette JD, Walsh MN, et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J. 2003;146:705-12.
91. Kimmelstiel C, Levine D, Perry K, et al. Randomized, controlled evaluation of short-and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial. Circulation. 2004;110:1450-5.
92. Koelling TM, Johnson ML, Cody RJ, Aaronson KD. Discharge education improves clinical outcomes in patients with chronic heart failure. Circulation. 2005;111:179-85.
93. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1-82.
94. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol. 2006;48:e247-346.
95. Carlson MD, Wilkoff BL, Maisel WH, et al. Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines. Heart Rhythm. 2006;3:1250-73.
96. Moss AJ. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator? Everyone with an ejection fraction or = 30% should receive an implantable cardioverter-defibrillator. Circulation. 2005;111:2537-49.
97. Kies P, Bootsma M, Bax J, Schalij MJ, van der Wall EE. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: screening, diagnosis, and treatment. Heart Rhythm. 2006;3:225-34.
98. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37.
99. Stevenson WG, Epstein LM. Predicting sudden death risk for heart failure patients in the implantable cardioverter-defibrillator age. Circulation. 2003;107:514-6.
100. Exner DV, Klein GJ, Prystowsky EN. Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease: can we afford to do it? (Can we afford not to?). Circulation. 2001;104:1564-70.
101. Spirito P, Bellone P, Harris KM, et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 2000;342:1778-85.
102. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med. 1997;337:1569-75.
103. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). J Am Coll Cardiol. 2008;51:e1-62.
104. Kadish A, Schaechter A, Subacius H, et al. Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2477-82.
105. Marchlinski FE, Jessup M. Timing the implantation of implantable cardioverter-defibrillators in patients with nonischemic cardiomyopathy. J Am Coll Cardiol. 2006;47:2483-5.
106. Cesario DA, Dec GW. Implantable cardioverter-defibrillator therapy in clinical practice. J Am Coll Cardiol. 2006;47:1507-17.
107. Rozner MA. The patient with a cardiac pacemaker or implanted defibrillator and management during anaesthesia. Curr Opin Anaesthesiol. 2007;20:261-8.
108. Goldenberg I, Moss AJ. Treatment of arrhythmias and use of implantable cardioverter-defibrillators to improve survival in elderly patients with cardiac disease. Clin Geriatr Med. 2007;23:205-19.
109. Gehi AK, Mehta D, Gomes JA. Evaluation and management of patients after implantable cardioverter-defibrillator shock. JAMA. 2006;296:2839-47.
110. Sears SF Jr., Stutts LA, Aranda JM Jr., et al. Managing congestive heart failure patient factors in the device era. Congest Heart Fail. 2006;12:335-40.
111. Kusumoto F, Goldschlager N. Implantable cardiac arrhythmia devices-Part II: implantable cardioverter defibrillators and implantable loop recorders. Clin Cardiol. 2006;29:237-42.
112. Winslow RD, Pinney S, Fuster V. Impact of implantablecardioverter- defibrillator trials on clinical management of patients with heart failure. Nat Clin Pract Cardiovasc Med. 2006;3:86-93.
113. O'Brien MC, Langberg J, Valderrama AL, et al. Implantable cardioverter defibrillator storm: nursing care issues for patients and families. Crit Care Nurs Clin North Am. 2005;17:9-16, ix.
114. Bourge RC. Case studies in advanced monitoring with the Chronicle device. Rev Cardiovasc Med. 2006;7 Suppl 1:S56-61.
115. Pamboukian SV, Smallfield MC, Bourge RC. Implantable hemodynamic monitoring devices in heart failure. Curr Cardiol Rep. 2006;8:187-90.
116. Small RS. Integrating device-based monitoring into clinical practice: insights from a large heart failure clinic. Am J Cardiol. 2007;99:17G-22G.
117. Hosseinpour AR, Cullen S, Tsang VT. Transplantation for adults with congenital heart disease. Eur J Cardiothorac Surg. 2006;30:508-14.
118. Wray J, Sensky T. Congenital heart disease and cardiac surgery in childhood: effects on cognitive function and academic ability. Heart. 2001;85:687-91.
119. Pigula FA, Gandhi SK, Ristich J, et al. Cardiopulmonary transplantation for congenital heart disease in the adult. J Heart Lung Transplant. 2001;20:297-303.
120. Lamour JM, Addonizio LJ, Galantowicz ME, et al. Outcome after orthotopic cardiac transplantation in adults with congenital heart disease. Circulation. 1999;100:II200-5.
121. Shaddy RE, Webb G. Applying heart failure guidelines to adult congenital heart disease patients. Expert Rev Cardiovasc Ther. 2008;6:165-74.
122. Vonder M, Muhl I, Liu P, Webb G. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease. Int J Cardiol. 2004;97 Suppl 1:25-33.
123. Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46:2277-83.
124. McCrindle BW, Williams RV, Mitchell PD, et al. Relationship of patient and medical characteristics to health status in children and adolescents after the Fontan procedure. Circulation. 2006;113:1123-9.
125. Dimopoulos K, Diller GP, Piepoli MF, Gatzoulis MA. Exercise intolerance in adults with congenital heart disease. Cardiol Clin. 2006;24:641-60, vii.
126. Reybrouck T, Mertens L. Physical performance and physical activity in grown-up congenital heart disease. Eur J Cardiovasc Prev Rehabil. 2005;12:498-502.
127. Bernstein D, Naftel D, Chin C, et al. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006;114:273-80.
128. Gibbs JS, McCoy AS, Gibbs LM, et al. Living with and dying from heart failure: the role of palliative care. Heart. 2002;88 Suppl 2:ii36-9.
129. National Consensus Project for Quality Palliative Care. Clinical practice guidelines for quality palliative care. 2nd ed. Available at: http://www.nationalconsensusproject.org/guideline.pdf. Accessed May 25, 2010.
130. McCarthy M, Lay M, Addington-Hall J. Dying from heart disease. J R Coll Physicians Lond. 1996;30:325-8.
131. Levenson JW, McCarthy EP, Lynn J, et al. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc. 2000;48:S101-9.
132. ACGME Program Requirements for Graduate Medical Education in Hospice and Palliative Medicine: Companion Document: Core Competencies for Hospice and Palliative Medicine Fellowship Training. 2008. Available at: http://www.acgme.org/acWebsite/downloads/RRC-progReg/540-hospice-and-palliative- medicine- companion-02122008.pdf. Accessed May 25, 2010.
133. Baruch-Bienen DL. Ethics and Palliative Care. Available at: http://pier.acponline.org/physicians/ethical-legal/e1755/pdf/e1755.pdf. Accessed December 10, 2007.
134. Committee on Care at the End of Life, Division of Health Care Services, Institute of Medicine. Educating clinicians and other professionals. In: Field MJ, Cassel CK, eds. Approaching death: improving care at the end of life. Washington, DC: National Academies Press;1997:207-34.
135. Americans With Disabilities Act. 42 USC §12101 (1990).
136. Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ. 2003;326:30-4.
137. Brody H, Campbell ML, Faber-Langendoen K, Ogle KS. Withdrawing intensive life-sustaining treatment: recommendations for compassionate clinical management. N Engl J Med. 1997;336:652-7.
138. Heart Transplant Statistics. Available at: http://www.americanheart. org/presenter.jhtml?identifier=4588. Accessed January 17, 2007.
139. Roccaforte R, Demers C, Baldassarre F, et al. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in heart failure patients: a meta-analysis. Eur J Heart Fail. 2005;7:1133-44.
140. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725-32.
141. Grady KL, Dracup K, Kennedy G, et al. Team management of patients with heart failure: a statement for healthcare professionals from the Cardiovascular Nursing Council of the American Heart Association. Circulation. 2000;102:2443-56.
142. Medicare Program; Hospital Conditions of Participation: Requirements for Approval and Re-Approval of Transplant Centers To Perform Organ Transplants. Federal Register. Vol. 72, No. 61. Page 15197-280. Available at: http://frwebgate3.access.gpo.gov/cgi-bin/waisgate.cgi?WAISdocID= 489800705+20+0+0&WAISaction= retrieve. Accessed September 15, 2008.